<?xml version="1.0" encoding="utf-8" standalone="no"?>
<measures>
  <measure>
    <type>Main</type>
    <parent-measure></parent-measure>
    <title>Percentage of NDI notification reviews completed to which FDA objected</title>
    <dictionary>Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety.  Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.</dictionary>
    <dictionary>&lt;i&gt;Information is current as of December 31, 2012.&lt;/i&gt;</dictionary>
    <footnotes>
      <note></note>
    </footnotes>
    <measure-description>Percentage</measure-description>
    <chart-type>column</chart-type>
    <chart-color></chart-color>
    <right-min></right-min>
    <right-max></right-max>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>100</chart-max>
      <title>2010</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2010 6 Month Overall: 50%</summary>
      <time>
        <frame>Oct 2009</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Nov 2009</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Dec 2009</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Jan 2010</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Feb 2010</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Mar 2010</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Apr 2010</frame>
        <target></target>
        <value>0</value>
      </time>
      <time>
        <frame>May 2010</frame>
        <target></target>
        <value>29</value>
      </time>
      <time>
        <frame>Jun 2010</frame>
        <target></target>
        <value>60</value>
      </time>
      <time>
        <frame>Jul 2010</frame>
        <target></target>
        <value>60</value>
      </time>
      <time>
        <frame>Aug 2010</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Sep 2010</frame>
        <target></target>
        <value>N/A</value>
      </time>
    </fiscal-year>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>100</chart-max>
      <title>2011</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2011 Overall: 70%</summary>
      <time>
        <frame>Oct 2010</frame>
        <target></target>
        <value>80</value>
      </time>
      <time>
        <frame>Nov 2010</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Dec 2010</frame>
        <target></target>
        <value>67</value>
      </time>
      <time>
        <frame>Jan 2011</frame>
        <target></target>
        <value>75</value>
      </time>
      <time>
        <frame>Feb 2011</frame>
        <target></target>
        <value>75</value>
      </time>
      <time>
        <frame>Mar 2011</frame>
        <target></target>
        <value>67</value>
      </time>
      <time>
        <frame>Apr 2011</frame>
        <target></target>
        <value>87</value>
      </time>
      <time>
        <frame>May 2011</frame>
        <target></target>
        <value>0</value>
      </time>
      <time>
        <frame>Jun 2011</frame>
        <target></target>
        <value>67</value>
      </time>
      <time>
        <frame>Jul 2011</frame>
        <target></target>
        <value>50</value>
      </time>
      <time>
        <frame>Aug 2011</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Sep 2011</frame>
        <target></target>
        <value>75</value>
      </time>
    </fiscal-year>
    <fiscal-year>
      <chart-min></chart-min>
      <chart-max></chart-max>
      <title>2012</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2012 Overall: 80%</summary>
      <time>
        <frame>Oct 2011</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Nov 2011</frame>
        <target></target>
        <value>80</value>
      </time>
      <time>
        <frame>Dec 2011</frame>
        <target></target>
        <value>75</value>
      </time>
      <time>
        <frame>Jan 2012</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Feb 2012</frame>
        <target></target>
        <value>50</value>
      </time>
      <time>
        <frame>Mar 2012</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Apr 2012</frame>
        <target></target>
        <value>83</value>
      </time>
      <time>
        <frame>May 2012</frame>
        <target></target>
        <value>50</value>
      </time>
      <time>
        <frame>Jun 2012</frame>
        <target></target>
        <value>100</value>
      </time>
      <time>
        <frame>Jul 2012</frame>
        <target></target>
        <value>83</value>
      </time>
      <time>
        <frame>Aug 2012</frame>
        <target></target>
        <value>67</value>
      </time>
      <time>
        <frame>Sep 2012</frame>
        <target></target>
        <value>67</value>
      </time>
    </fiscal-year>
<fiscal-year>
      <chart-min></chart-min>
      <chart-max></chart-max>
      <title>2013</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2013 YTD: 79%</summary>
      <time>
        <frame>Oct 2012</frame>
        <target></target>
        <value>N/A</value>
      </time>
      <time>
        <frame>Nov 2012</frame>
        <target></target>
        <value>75%</value>
      </time>
      <time>
        <frame>Dec 2012</frame>
        <target></target>
        <value>83%</value>
      </time>
      <time>
        <frame>Jan 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Feb 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Mar 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Apr 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>May 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Jun 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Jul 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Aug 2013</frame>
        <target></target>
        <value></value>
      </time>
      <time>
        <frame>Sep 2013</frame>
        <target></target>
        <value></value>
      </time>
    </fiscal-year>
  </measure>
 <related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206221.htm</url><text>FDA-TRACK CFSAN Dashboard</text></link></related-links>
</measures>਍††਍਍਍਍਍਍਍